Development of radiomic-based model to predict clinical outcomes in non-small cell lung cancer patients treated with immunotherapy

HIGHLIGHTS

  • who: Olena Tankyevych and collaborators from the Nuclear Medicine Department, Poitiers University Hospital, Poitiers, France have published the article: Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy, in the Journal: (JOURNAL)
  • what: The authors aimed to assess the ability of radiomics features extracted from baseline (PET/CT0) and follow-up PET/CT scans as well as their evolution (delta-radiomics) to predict clinical outcome (durable clinical benefit (DCB) progression response to therapy OS and PFS) in non-small cell lung cancer (NSCLC) patients treated . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?